[PDF][PDF] SFA disease: deciding what to leave behind

MW Burket - Endovasc Today, 2019 - assets.bmctoday.net
Services provided a transitional pass through (TPT) payment, which offset the additional up-
front cost incurred by hospitals when outpatient FP interventions included DCB use. Thus …

[PDF][PDF] SFA disease: Facing reality

T OHKI - Endovasc Today, 2005 - evtoday.com
COVER STORY “... the SFA is a very harsh environment for any endovascular device.” of the
control arm, which utilized the bare nitinol Smart stents (Cordis Endovascular, a Johnson & …

1178 Management of SFA Disease Delineated by Disease Type–a Multicentre European Analysis

N Fitzpatrick, R Owen, A Sherazi… - British Journal of …, 2023 - academic.oup.com
Aim The study aimed to assess how SFA disease is treated in patients with critical limb
ischaemia and patients with claudication. Method Data was collected from the …

[PDF][PDF] Scoring and cutting balloons for SFA disease treatment

M Bosiers, K Deloose, J Verbist, P Peeters - Endovascular Today, 2008 - evtoday.com
COVER STORY the coronary arteries by Dr. Peter Barath and was initially called the Barath
Balloon. 6 The device is composed of a conventional balloon catheter with 3 to 4 …

Commentary: Be Innovative, Stay Clinical! Time for a Patient-Specific SFA Treatment Algorithm?

M Midulla, R Loffroy, M Dake - Journal of endovascular …, 2020 - journals.sagepub.com
Midulla et al 503 reimbursed in different health systems and even variable in the same
country. Nevertheless, physical exercise, either SET or home-based exercise training, has …

[引用][C] Provisionial SFA stenting

MC Bates - Catheterization and Cardiovascular Interventions, 2007 - Wiley Online Library
Placing stents in the superficial femoral artery (SFA) provides crisp clean angiographic
vessel boundaries that admittedly leave the operator with a gratifying feeling during the …

Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents

M Bosiers, K Deloose, J Verbist… - Journal of …, 2008 - search.proquest.com
The current evolution towards treating more complex femoropopliteal lesions as seen in the
renewed TASC II recommendations clearly reflects the continuous evolutions in …

Atherectomy plus antirestenotic therapy for SFA lesions: evolving evidence for better patency rates in complex lesions.

M Lichtenberg, G Korosoglou - The Journal of Cardiovascular …, 2019 - europepmc.org
Within the last years, many new endovascular treatment modalities have been invented for
treatment of peripheral arterial disease. To leave nothing behind and to keep options for …

[PDF][PDF] Does care drive reimbursement or vice versa?

TS DAS, Y Goueffic - Endovasc Today, 2017 - evtoday.com
SFA more complicated due to poor methodology, a bad primary endpoint, and/or the
absence of clinical improvement. Moreover, the lack of direct comparisons between devices …

[PDF][PDF] Nonstent endovascular treatment of SFA occlusions

RS Dieter, JR Laird - Endovascular Today, 2006 - evtoday.com
“Once SFA in-stent restenosis or occlusion occurs (particularly when it is diffuse), there is no
proven effective therapy.” ing concern about stent fracture, alternative nonstent options for …